References
- Chen F-P, Lee N, Wang Ch-H, et al. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women. Fertil Steril 1998;69,2:267–73
- Collins P. Vascular effects of estrogens. Menopause Rev 1997;II(2):12
- Lobo RA. Cardiovascular implication of estrogen replacement therapy. Obstet Gynecol 1990;75: 18-25S
- Nabulsi AA, Folsom AR, White A, et al. Associa-tion of ho rmone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069–75
- The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in p ostmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. J Am Med Assoc 1995;273:199–208
- Speroff L. Postmenopausal hormone therapy and coronary heart disease; clinical implications of recent randomised trial results. Maturitas 2000; 35:91–7
- Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/ progestin interventions (PEPI) trial. JAm Med Assoc 1996;276:1389–96
- Mosekilde L, Beck-Nielson H, Sorensen OH, etal. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women — results of the Danish Osteoporosis Pre-vention Study. Maturitas 2000;236:181–93
- Brincat MP. Hormone replacement therapy and the skin. Maturitas 2000;35:107–17
- Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996;156:2213–17
- Henderson VW. Sex steroids and Alzheimer's disease: therapeutic considerations. In: Birkhäuser MH, Rozenbaum H, eds. Proceedings of IV European Congress on Menopause. Vienna, Austria, 1998: 47–54
- Lobo RA. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1991;73:925–30
- Bohdanowicz-Pawlak A, Bednarek-Tupikowska G, Milewicz A. Wplyw leczenia hormonalnego na stOenie wybranych frakcji lipidowych w surowicy krwi kobiet po okresie menopauzy. Post Med Klin Dam 1995;4(2):231–6
- Barrett-Connor E, Bush TL. Estrogen and coro-nary heart disease. J Am Med Assoc 1991;265: 1861–7
- Maziere C, Auclair M, Ronveaux MC, et al. Estrogen inhibits copper and cell-mediated modifi-cation of low density lipoprotein. Atherosclerosis 1991;89:175–82
- Subbiach MTR, Kessel B, Agrawal M, et al. Anti-oxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993;77: 1095–7
- Tang M, Abplanalp W, Ayres S, etal. Superior and distinct antioxidant effects of selected estrogen metabolities on lipid peroxidation. Metabolism 1996;45(4):411–4
- Bednarek-Tupikowska G. Antyoksydacyjne wIakiwoki estrogenów. Gin Po/ 2000;In press
- Sack MN, Rader DJ, Cannon III RO. Oestrogen and inhibition of oxidation of low-density lipo-proteins in postmenopausal women. Lancet 1994; 343:269–70
- Wilcox JG, Hwang J, Hodis HN, et al. Cardio-protective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. Fertil Steril 1997;67 (1):57–62
- Kuhl H. Beyond hormonal action: are oestrogens effective free radicals scavengers? Maturitas 1993; 18:5–8
- Sugioka K, Shimosegawa, Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 1987;210:37–9
- Ayres S, Tang M, Subbiach TR. Estradio1-1713 as an antioxidant: some distinct features when com-pared with common fat-soluble antioxidants. J Lab Clin Med 1996;128: 367–75
- Massafra C, Buonocore G, Berni S, et al. Anti-oxidant erythrocyte enzyme activities during oral contraception. Contraception 1993;47:591–6
- Massafra C, Buono core G, Gioia D, et al. Effects of estradiol and medroxyprogesterone-acetate treat-ment on erythrocyte antioxidant enzyme activities and malonyldialdehyde plasma levels in amenorr-heic women. J Clin Endocrinol Metab 1997;82: 173–5
- Massafra C, De Felice C, Gioia D, et al. Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle. Clin Endocrinol 1998;49:64–7
- Kanaley JA, Ji LL. Antioxidant enzyme activity during prolonged exercise in amenorrheic and eumenorrheic athletes. Metabolism 1991;40(1): 88–92
- Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Med 1992;6:598–620
- Liechr JG. Antioxidant and prooxidant properties of estrogens. J Lab Clin Med 1996;128:344–5
- Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37–43
- Grodstein F, Stampfer M, Colditz GA, et al. Post-menopausal hormone therapy and mortality. N Eng1J Med 1997;336: 1769–75